Pharmaceuticals

Pharmaceutical Executive: June 2024 issue (PDF)

bexib
By bexib 0 Min Read

Click on the title above to open the June 2024 issue of Pharmaceutical Executive in an interactive PDF format.

You Might Also Like

FDA Approves Actinium Pharmaceuticals’ Investigational New Drug Application for Iomab-ACT for Patients with Sickle Cell Disease

Pharma Pulse 5/31/24: OpenAI says Russia and China used AI in covert operations, FDA diversity documents on clinical trials, and more

FDA grants breakthrough therapy designation to GSK’s GSK5764227 for relapsed or refractory extensive-stage small cell lung cancer

New Jersey doctor becomes first in state to use PathKeeper surgical navigation system on patients

Gene therapy that costs over $4 million?How can payers adapt to the new reality of expensive “cures”?

Share This Article
Previous Article Top 10 Print-on-Demand Book Services for Self-Publishing (2024)
Next Article From the Shockwave Report: Standing Up for Steel
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

FinTech financing: Datadirect Networks has $ 300 million
Banking
CFPB imposes a fine of $ 2.5 million in Fintech Wise
Banking
Within the city’s cloud migration strategy
Banking
Allstate that sells group health business nationwide
Insurance